Research prototype, not medical advice.

Diabetics on metformin show mortality similar to or lower than non-diabetics; observational data with possible biases.

Confidence
Debated
Level of evidence
Observations in humans
Observed in
Human
Mission
Map of aging (12 hallmarks)
Concepts
Deregulated nutrient sensingMetforminType 2 diabetesAMPK

What the sources say

Each row is an article. “Supports”: it backs the claim. “Contradicts”: it goes against it. “Qualifies”: it limits it (another species, a weaker effect…).

DirectionSourceWhere in the articleStatus
Supports Metformin reduces all-cause mortality and diseases of ageing independent of its effect on diabetes control: A systematic review and meta-analysis
Campbell et al. · Ageing Research Reviews 2017
— Verified
Supports Can people with type 2 diabetes live longer than those without? A comparison of mortality in people initiated with metformin or sulphonylurea monotherapy and matched, non‐diabetic controls
Bannister et al. · Diabetes, Obesity and Metabolism 2014
— Verified

Related claims